MALAT1 and hepatocellular carcinoma: MALAT1 may represent a potential non-invasive biomarker for HCV-related hepatocellular carcinoma (HCC) prognosis, via sponging miR-204, miR-143, miR-195, miR-490, miR-216b, miR-146-5p [45].